EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische Übersicht

Parathyroid Hormone for Medication‐Related Osteonecrosis of the Jaw: A Systematic Review and Meta‐Analysis

Lama Alabdulaaly iD, Abeer Ahmad Alfadhel, Ahad Zaid Bin Juwaid, Asma Almazyad iD

Oral Diseases · 01.11.2026

DOI: 10.1111/odi.70551 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oral Diseases, online erschienen am 01.11.2026. Verfasst von Lama Alabdulaaly und 3 weiteren Autor:innen. Beteiligte Einrichtung: Maxillofacial Surgery and Diagnostic Sciences Department, College of Dentistry, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi…. Die Arbeit nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medication‐related osteonecrosis of the jaw (MRONJ) is a complication of antiresorptive therapy and can be refractory to treatment. Teriparatide (TPTD) has shown promise in the management of MRONJ. We aimed to comprehensively evaluate the impact of TPTD on MRONJ prevention and healing.

Methods

We systematically searched PubMed, Web of Science, Embase, Ovid, and LILACS in December 2024 to include studies that utilized TPTD/abaloparatide MRONJ management or prevention. Correlation analysis, meta‐analysis, and meta‐regression analysis were conducted. Quality assessment was performed using the Joanna Briggs Institute tool.

Results

All studies used TPTD for MRONJ management. Twenty‐eight studies with 278 participants were included (TPTD n = 161; non‐TPTD n = 117). MRONJ improvement was noted in 90.1% of the TPTD‐treated group and 81.2% in the non‐TPTD‐treated group (odds ratio 5.81). The highest resolution rates were observed among patients who received a combination of surgical and non‐surgical interventions for MRONJ in both groups.

Conclusions

Our results suggest a possible positive effect of TPTD on MRONJ resolution, and TPTD may have a synergistic effect when combined with surgical and non‐surgical interventions. These results must be interpreted with caution since analyses were based on publications with a small number of cases and with variable outcome assessment reporting.

Schlagwörter

Stichwörter der Autor:innen

antiresorptive therapyjawosteonecrosisosteoporosisparathyroid hormone

Autor:innen und Institutionen

  • Maxillofacial Surgery and Diagnostic Sciences Department, College of Dentistry, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Dental Services Department, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • King Abdullah International Medical Center, Riyadh, Saudi Arabia.
  • Department of Infection, Immunity, and Oral Medicine, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
  • College of Dentistry, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

ORCID-Profile: Lama Alabdulaaly, Asma Almazyad

Zitieren

APA

Alabdulaaly, L., Alfadhel, A. A., Juwaid, A. Z. B., & Almazyad, A. (2026). Parathyroid Hormone for Medication‐Related Osteonecrosis of the Jaw: A Systematic Review and Meta‐Analysis. Oral Diseases. https://doi.org/10.1111/odi.70551

Vancouver

Alabdulaaly L, Alfadhel AA, Juwaid AZB, Almazyad A. Parathyroid Hormone for Medication‐Related Osteonecrosis of the Jaw: A Systematic Review and Meta‐Analysis. Oral Diseases. 2026. doi:10.1111/odi.70551

BibTeX
@article{Alabdulaaly2026,
  author = {Alabdulaaly, Lama and Alfadhel, Abeer Ahmad and Juwaid, Ahad Zaid Bin and Almazyad, Asma},
  title = {Parathyroid Hormone for Medication‐Related Osteonecrosis of the Jaw: A Systematic Review and Meta‐Analysis},
  journal = {Oral Diseases},
  year = {2026},
  doi = {10.1111/odi.70551}
}
Kostenlos starten →